Skip to main content
Caplight Logo









Focai Bio

Focai Bio

Private
—Healthcare & Life Scienceshttps://focai.bio/

Last Round

Accelerator

Mar 13, 2026

Total Funding Raised

$100,000

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Focai Bio operates in Healthcare & Life Sciences. Its latest recorded funding round was an Accelerator round in March 2026.

Focai Bio is a biotechnology company that provides an AI-enabled platform for the quantification and design of drug distribution to improve therapy selection and response.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Drug Discovery, Precision Medicine, Biotech Equipment

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

Focai Bio Comparables

Compare Focai Bio with similar companies based on industry and business-model similarity.

Focai Bio comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Flagship Biosciences
77%
Aliri
73%
Pixelgen Technologies
70%
Book a demo to see all comparables

For institutional investors. Book with your work email.

Focai Bio Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
AcceleratorMar 13, 2026
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

Focai Bio Investors

Notable investors and investment history

Focai Bio investors
InvestorRounds
Consortium Québécois sur la découverte du médicamentAccelerator
The Venture CollectiveAccelerator

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 13, 2026

    $100K raised from Merck, The Venture Collective, and others.

Book a demo to see all signals

For institutional investors. Book with your work email.

Focai Bio Filings

Explore SEC and related filing metadata, where available.

Focai Bio filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about Focai Bio's valuation, stock price, and market status.

Is Focai Bio a public or private company?

Focai Bio is a private company.

What is the current stock price of Focai Bio?

Focai Bio is a private company, so its shares have no public market price. Caplight tracks Focai Bio's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is Focai Bio worth (valuation)?

Valuation information for Focai Bio is not publicly available.

Can I buy Focai Bio stock?

Focai Bio shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was Focai Bio's last funding round?

Focai Bio's most recent funding round was Accelerator on March 13, 2026.

Who are the main investors in Focai Bio?

Key investors in Focai Bio include Consortium Québécois sur la découverte du médicament, The Venture Collective.

Will Focai Bio IPO soon?

No public IPO plans have been announced for Focai Bio.

How can I track Focai Bio secondary market activity?

Caplight tracks bids, offers, and trades in Focai Bio's shares on secondary markets.

Firmographic Details

Headquarters—
Year FoundedN/A
Last FundingMar 13, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?